The WBE blog offers detailed insights, updates and commentary on current events related to class action and multidistrict lawsuits for consumers, businesses and investors. If there is a topic you would like to see covered in a future blog, contact us to let us know.
Featured Blog
No results found.
No results found.
Nearly One-Third of FDA Approved Drugs Pose Safety Risks
The film adaptation of Richard Matheson’s novel “I am Legend” is based on a simple premise: Scientists discover what appears to be a cure for cancer, and the whole world goes to hell ...
Device Deportation: Bayer to Discontinue Essure in Canada and Multiple European Countries
Essure, the permanent birth control device that has made numerous headlines around the world due to its high risk of complications, has not had the best year in regards to global markets. In ...
Dishonorable Discharge: Military Cuts Nexium from Preferred Drug List
The importance of allowing generic versions of “blockbuster” drugs onto the market is seldom talked about, but affects all of us. Access to generic drugs can significantly lower costs ...
State of California Investigation Links Cell Phone Use to Cancer
In 2010, the California Department of Public Health (CDPH) prepared a public guidance document warning exposure to EMFs (a type of radiation) emitted by cell phones could lead to brain ...
Taking Pre-Existing Conditions Back to Pre-Existing Times and the Demise of Medicaid
The struggle for Congressional Republicans to repeal and replace the Affordable Care Act (“ACA”) continues. As I reported in my last blog post, Republicans have been scrambling for ...
Welcome to the All-New WexlerWallace.com!
As you may have noticed, our website looks a little different. WexlerWallace.com has been the hub of information for the numerous cases our firm has brought on behalf of our clients. Anyone who ...
No results found.